Immuno-Oncology Assay Market Size & Insights
According to MarkNtel Advisors study The future of Global Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.25% during the forecast period, i.e., 2025-30.
What are the Key Driver in the Immuno-Oncology Assay Market?
Rising Cancer Cases Globally to Drive Immuno-Oncology Assay – The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory.
This surge in cancer cases has underscored the imperative for effective management. Consequently, countries, particularly the United States and India, have implemented measures to combat cancer, leading to heightened awareness among patients. This heightened awareness has driven the need for immune-oncology assays globally, catering to the need for early-stage detection and diagnosis.
Furthermore, global cancer research and healthcare organizations predict a continued increase in cancer cases in the years ahead. This prediction is based on factors such as the proliferation of carcinogenic pollutants in the environment and the growing prevalence of genetic mutations as significant contributors to cancer development. As a result, the demand for better immune-oncology diagnostic services would amplify in the coming years as well.
What are the Key Segments in the Immuno-Oncology Assay Market?
The Immuno-Oncology Assay is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:
· By Product & Services
o Reagents and Antibodies- Market Size & Forecast 2020-2030F, USD Million
o Testing Kits- Market Size & Forecast 2020-2030F, USD Million
o Instruments- Market Size & Forecast 2020-2030F, USD Million
o Consumables & Accessories- Market Size & Forecast 2020-2030F, USD Million
o Software- Market Size & Forecast 2020-2030F, USD Million
· By Assay Type
o Checkpoint Inhibitor Assays- Market Size & Forecast 2020-2030F, USD Million
o Cytokine Profiling Assays- Market Size & Forecast 2020-2030F, USD Million
o Protein Biomarker Assays- Market Size & Forecast 2020-2030F, USD Million
o Genomic Sequencing and Mutational Analysis- Market Size & Forecast 2020-2030F, USD Million
o Immune Profiling Assays- Market Size & Forecast 2020-2030F, USD Million
o Tumour Biomarker Assays- Market Size & Forecast 2020-2030F, USD Million
o Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)- Market Size & Forecast 2020-2030F, USD Million
· By Technology
o Polymerase Chain Reaction- Market Size & Forecast 2020-2030F, USD Million
o Immunoassay- Market Size & Forecast 2020-2030F, USD Million
o Next-generation Sequencing- Market Size & Forecast 2020-2030F, USD Million
o In-situ Hybridization- Market Size & Forecast 2020-2030F, USD Million
o Flow Cytometry- Market Size & Forecast 2020-2030F, USD Million
o Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.) - Market Size & Forecast 2020-2030F, USD Million
· By Indication
o Lung Cancer- Market Size & Forecast 2020-2030F, USD Million
o Breast Cancer- Market Size & Forecast 2020-2030F, USD Million
o Colorectal Cancer- Market Size & Forecast 2020-2030F, USD Million
o Prostate Cancer- Market Size & Forecast 2020-2030F, USD Million
o Ovarian Cancer- Market Size & Forecast 2020-2030F, USD Million
o Others (Bladder Cancer, Melanoma, etc.)- Market Size & Forecast 2020-2030F, USD Million
Among them all, the Prostate cancer segment commands the largest share in the market. This is primarily due to the increasing prevalence of prostate cancer worldwide. Prostate cancer ranks among the most common cancers in men, emphasizing the critical need for early diagnosis to determine appropriate treatment strategies.
Boost Your Company's Decisions by Getting a Free Sample Right Away- https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html
· By Application
o Clinical Assay- Market Size & Forecast 2020-2030F, USD Million
o Research & Development- Market Size & Forecast 2020-2030F, USD Million
· By End User
o Hospitals- Market Size & Forecast 2020-2030F, USD Million
o Cancer Research Centers- Market Size & Forecast 2020-2030F, USD Million
o Specialty Cancer Clinics- Market Size & Forecast 2020-2030F, USD Million
o Clinical Laboratories- Market Size & Forecast 2020-2030F, USD Million
o Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.) - Market Size & Forecast 2020-2030F, USD Million
How does geographical analysis highlight in the Immuno-Oncology Assay market?
· By Region
o North America
o South America
o Europe
o Middle East & Africa
o Asia-Pacific
North America's pre-eminence in the global Immuno-Oncology Assay Market is underpinned by a multifaceted landscape shaped by various factors.
Who are the Key Players in Immuno-Oncology Assay Market?
- Gogoro
- Yamaha
- Sanyang Motor Co., Ltd
- Yadea Group Holdings Ltd.
- Vmoto Soco Group
- NIU Technologies
- EZYRIDE
- Ather
- Others
Browse Full Reports - https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html
Immuno-Oncology Assay Market News
· 2025: Agilent Technologies Inc. announced an extended partnership with Incyte to boost the development and commercialization of Incyte’s hematology and oncology portfolio. This collaboration focuses on incorporating advanced assay technologies to support precision diagnostics and targeted therapies.
Key pillars of the research methodology include:
· Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets.
· Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations.
· Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias.
· Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations.
"Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide," said a spokesperson for MarkNtel Advisors.
Why This MarkNtel Advisors Research Report:
- In-depth Market Analysis: Understand trends and dynamics shaping growth.
- Segmented Insights: Target specific segments for focused strategies.
- Geographical Performance: Assess market opportunities by geographic area.
- Emerging Technologies: Discover advancements like AI integration.
- Risk Identification: Pinpoint challenges to inform strategic planning.
- Future Forecasts: Prepare for market changes with actionable projections.
Gain exclusive access to our comprehensive insights on the Future of Immuno-Oncology Assay Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.
Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/immuno-oncology-assay-market.html
Our Trusted Experts Are Here to Help:
At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.
Reach Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
Visit our Website: https://www.marknteladvisors.com
Trending Blogs - https://www.marknteladvisors.com/blogs